A detailed history of Fin Trust Capital Advisors, LLC transactions in Danaher Corp stock. As of the latest transaction made, Fin Trust Capital Advisors, LLC holds 915 shares of DHR stock, worth $211,621. This represents 0.04% of its overall portfolio holdings.

Number of Shares
915
Previous 917 0.22%
Holding current value
$211,621
Previous $229,000 10.92%
% of portfolio
0.04%
Previous 0.04%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$239.25 - $280.76 $478 - $561
-2 Reduced 0.22%
915 $254,000
Q2 2024

Jul 24, 2024

BUY
$235.51 - $267.98 $6,358 - $7,235
27 Added 3.03%
917 $229,000
Q4 2023

Feb 13, 2024

BUY
$185.1 - $233.13 $3,146 - $3,963
17 Added 1.95%
890 $205,000
Q3 2023

Oct 24, 2023

BUY
$233.08 - $265.59 $6,293 - $7,170
27 Added 3.19%
873 $216,000
Q3 2022

Oct 20, 2022

BUY
$247.06 - $1507.4 $741 - $4,522
3 Added 0.36%
846 $225,000
Q2 2022

Jul 26, 2022

BUY
$237.11 - $299.66 $22,525 - $28,467
95 Added 12.7%
843 $231,000
Q1 2022

May 03, 2022

SELL
$257.27 - $315.76 $22,639 - $27,786
-88 Reduced 10.53%
748 $220,000
Q1 2021

May 17, 2021

BUY
$212.38 - $245.9 $50,121 - $58,032
236 Added 39.33%
836 $188,000
Q3 2020

Nov 10, 2020

SELL
$177.16 - $215.33 $16,298 - $19,810
-92 Reduced 13.29%
600 $129,000
Q2 2020

Sep 11, 2020

BUY
$128.7 - $176.83 $89,060 - $122,366
692 New
692 $122,000
Q2 2020

Aug 14, 2020

SELL
$128.7 - $176.83 $81,081 - $111,402
-630 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$121.39 - $169.05 $13,595 - $18,933
-112 Reduced 15.09%
630 $87,000
Q4 2019

Jan 23, 2020

SELL
$133.47 - $153.48 $26,694 - $30,695
-200 Reduced 21.23%
742 $114,000
Q2 2019

Aug 01, 2019

BUY
$124.88 - $143.73 $22,728 - $26,158
182 Added 23.95%
942 $134,000
Q1 2019

May 09, 2019

BUY
$97.62 - $132.29 $7,223 - $9,789
74 Added 10.79%
760 $100,000
Q4 2018

Feb 11, 2019

BUY
$94.85 - $109.54 $65,067 - $75,144
686 New
686 $71,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Fin Trust Capital Advisors, LLC Portfolio

Follow Fin Trust Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.